Clinical Trial Update: Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing prolonged adjuvant temozolomide with a 'Stop & Go' strategy in glioblastoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Glioblastoma | Phase 2 | Status: UNKNOWN